11
Rodney C Schnur: Hypoglycemic 5-substituted oxazolidine-2,4-diones. Pfizer, Charles J Knuth, Albert E Frost, Robert K Blackwood, June 1, 1982: US04332952 (12 worldwide citation)

Hypoglycemic 5-furyl and 5-thienyl derivatives of oxazolidine-2,4-dione and the pharmaceutically-acceptable salts thereof; certain 3-acylated derivatives thereof; and intermediates useful in the preparation of said compounds.


12
Rodney C Schnur: Novel spiro-oxazolidinediones. Pfizer, Francis X Murphy, Charles J Knuth, Peter C Richardson, October 7, 1980: US04226875 (10 worldwide citation)

Novel spiro-oxazolidinediones useful as aldose reductase inhibitors and as therapeutic agents for the treatment of chronic diabetic complications are disclosed. Pharmaceutical compositions containing the novel compounds and a method of treating chronic diabetic complications are also disclosed.


13
Rodney C Schnur: Hypoglycemic 5-substituted oxazolidine-2,4-diones. Pfizer, Peter C Richardson, Albert E Frost, Robert K Blackwood, June 28, 1988: US04753956 (9 worldwide citation)

Hypoglycemic 5-chromanyl, 2,3-dihydro-5-benzo[b]-furanyl, 5-pyridyl, 5-quinolyl, 5-pyrrolyl, 5-indolyl, 5-thiazolyl, 5-oxazolyl, 5-isothiazolyl and 5-isoxazolyl oxazolidine-2,4-diones and the pharmaceutically-acceptable salts thereof; certain 3-acylated derivatives thereof; a method of treating hype ...


14
Rodney C Schnur, Anton F J Fliri: Benzamide protease inhibitors. Pfizer, Peter C Richardson, J Trevor Lumb, James M McManus, August 14, 1990: US04948901 (9 worldwide citation)

Compounds of the formula ##STR1## where HET is a heterocyclic group, n is an integer of 0 to 2 and R.sup.1 is hydrogen or lower alkyl are protease inhibitors useful as anti-plasmin and antithrombin agents.


15

16
Rodney C Schnur: Hypoglycemic 5-substituted oxazolidine-2,4-diones. Pfizer, Charles J Knuth, Albert E Frost, Robert K Blackwood, October 4, 1983: US04407811 (5 worldwide citation)

Hypoglycemic 5-phenyl and 5-naphthyl oxazolidine-2,4-diones and the pharmaceutically-acceptable salts thereof; certain 3-acylated derivatives thereof; a method of treating hyperglycemic animals therewith; and intermediates useful in the preparation of said compounds.


17
Rodney C Schnur: Hypoglycemic 5-phenyl-substituted oxazolidine-2,4-diones. Pfizer, Charles J Knuth, Albert E Frost, Robert K Blackwood, May 15, 1984: US04448971 (5 worldwide citation)

Hypoglycemic 5-phenyl and 5-naphthyl oxazolidine-2,4-diones and the pharmaceutically-acceptable salts thereof; certain 3-acylated derivatives thereof; a method of treating hyperglycemic animals therewith; and intermediates useful in the preparation of said compounds.


18
Rodney C Schnur: Hypoglycemic 5-substituted oxazolidine 2,4-diones. Pfizer, Peter C Richardson, Albert E Frost, Robert K Blackwood, August 25, 1987: US04689336 (4 worldwide citation)

Hypoglycemic 5-chromanyl, 2,3-dihydro-5-benzo[b]-furanyl, 5-pyridyl, 5-quinolyl, 5-pyrrolyl, 5-indolyl, 5-thiazolyl, 5-oxazolyl, 5-isothiazolyl and 5-isoxazolyl oxazolidine-2,4-diones and the pharmaceutically-acceptable salts thereof; certain 3-acylated derivatives thereof; a method of treating hype ...


19
Rodney C Schnur: Tetracyclic spiro-hydantoin aldose reductase inhibitors and compositions. Pfizer, Charles J Knuth, Peter C Richardson, Mark Dryer, April 7, 1987: US04656169 (4 worldwide citation)

Novel biologically-active tetracyclic spiro-hydantoin derivatives which are potent inhibitors of aldose reductase and useful in treating diabetic complications are disclosed. Pharmaceutical compositions containing the novel compounds and a method of treating chronic diabetic complications are also d ...


20
Rodney C Schnur: Isoquinoline acetic acids. Pfizer, Charles J Knuth, Peter C Richardson, August 11, 1981: US04283539 (4 worldwide citation)

Novel isoquinoline acetic acids and derivatives thereof useful as aldose reductase inhibitors and as therapeutic agents for the treatment of chronic diabetic complications, especially diabetic cataracts are disclosed. Also disclosed are pharmaceutical compositions containing the novel compounds of t ...